Dr. Sud Agarwal is an accomplished physician and entrepreneur with extensive experience in the fields of medicinal cannabis and psychedelic therapies. He co-founded Cannvalate, Australia’s first medically backed cannabis company, facilitating the entry of global cannabis producers into the Australian market. Dr. Agarwal has also played a pivotal role in advancing psychedelic research and drug development as the founder of iNGENū CRO and Shanti Therapeutics, which focus on clinical trials for psychedelics and pain management therapies.